Interim report Q1 2024

Revenio Group Corporation’s January-March 2024 Interim report was published on Thursday, April 25. See result materials below.

Welcome to Revenio's investor website

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD).



Outlook and guidance

See our guidance

Upcoming events

Latest video

Investor contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi